Author

Matthew Taylor

Observed name: Taylor, Matthew Craig

Institutions: University of Dundee, GlaxoSmithKline (United Kingdom), MRC Protein Phosphorylation and Ubiquitylation Unit, Medical Research Council

Observed institutions: University of Dundee, GlaxoSmithKline (United Kingdom), MRC Protein Phosphorylation and Ubiquitylation Unit, Medical Research Council

ORCID: 0000-0002-4003-3128

Observed ORCID: 0000-0002-4003-3128

OpenAlex ID: A5000399121

Advances in elucidating the function of leucine-rich repeat protein kinase-2 in normal cells and Parkinson's disease

2020 · Matthew Taylor, Dario R. Alessi · Current Opinion in Cell Biology · 128

Development of a multiplexed targeted mass spectrometry assay for LRRK2-phosphorylated Rabs and Ser910/Ser935 biomarker sites

2020 · Raja S. Nirujogi, Francesca Tonelli, et al. · Biochemical Journal · 55

Deciphering the LRRK code: LRRK1 and LRRK2 phosphorylate distinct Rab proteins and are regulated by diverse mechanisms

2021 · Asad U. Malik, Athanasios Karapetsas, et al. · Biochemical Journal · 48

Parkinson’s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B

2023 · Prosenjit Pal, Matthew Taylor, et al. · Science Advances · 37

Inflammation and IL-4 regulate Parkinson’s and Crohn’s disease associated kinase LRRK2

2025 · Dina Dikovskaya, Rebecca Pemberton, et al. · EMBO Reports · 7

Author Reply to Peer Reviews of Regulation of Leucine-Rich Repeat Kinase 2 by inflammation and IL-4

2024 · Dina Dikovskaya, Rebecca Pemberton, et al.

Parkinson's disease and xenobiotic metabolism

2001 · Taylor, Matthew Craig · ANU Open Research (Australian National University)

Works count: 7

Citation count: 275

H-index: 5

I10-index: 4